Angiopoietin-Like Protein 3 Human ELISA

Regulatery Status: RUO
Type: Sandwich ELISA, Biotin-labelled antibody
Other Names Status: Angiopoietin-related protein 3, Angiopoietin-5, ANG-5, ANGPT5, UNQ153/PRO179, ANGPTL-3
Species: Human
Catalog No Size
Product Catalog No: RD191092200R Pack Size: 96 wells (1 kit)

Pack Size:
Pack Size:
Pack Size:
Pack Size:

Category:
Product Features

Angiopoietin-like Protein 3 (Angptl3) is one from six members of Angiopoietin-like (Angptl) family of proteins, which has been identified as orphan ligands with structural similarity to angiopoietins. Angptl3 has 490-amino acid residues and its expression is restricted to the liver.
Angptl3 and Angptl4 have been shown to regulate fat, lipid or glucose metabolic homeostasis. Angptl3 is a hepatocyte-derived circulating factor that affect lipid metabolism and is involved in regulating lipid storage and breakdown.
Overexpression of Angptl3 or intravenous injection of the purified protein in mice elicited an increase in circulating plasma lipid levels. Angptl3 decreases very low density lipoprotein (VLDL) triglyceride clearance by inhibiting lipoprotein lipase (LPL) activity, directly targeting adipose cells to activate lipolysis. This results in an increased release of free fatty acid (FFA) and glycerol from adipocytes. These observations indicate that Angptl3 might regulate lipid metabolism by inhibiting LPL and by stimulating lipolysis in adipocytes.
Recent findings suggest that elevated levels of Angptl3 in diabetic states might be involved in inducing hypertriglyceridemia and hyperfattyacidemia in diabetes and obesity. Hypertriglyceridemia causes triglyceride accumulation in peripheral tissues such as skeletal muscles to enhance insulin- and leptin- resistance, and in vessel walls to induce atherosclerosis. Hyperfattyacidemia also affects the regulation of insulin secretion.
Taken together, these findings suggest that abnormalities in the regulation of Angptl3 might be involved in the pathogenesis of metabolic syndrome.
Angptl3 also suggest a possible role in the regulation of proliferation of new vessel from preexisting capillaries; a process termed angiogenesis also plays a key role in the progression of solid tumor growth, diabetic retinopathies, psoriasis, inflammation, and rheumathoid arthritis.

Areas of investigation: Lipid metabolism, Angiogenesis, Atherosclerosis

Research topic

Energy metabolism and body weight regulation, Oncology

Techical Sheet / Info

Type

Sandwich ELISA, Biotin-labelled antibody

Applications

Serum, Plasma-EDTA, Plasma-Heparin, Plasma-Citrate

Sample Requirements

30 µl/well

Storage/Expiration

Store the complete kit at 2–8°C. Under this condition, the kit is stable until the expiration date (see the label on the box).

Calibration Curve

Calibration Range

12.5–400 ng/ml

Limit of Detection

1.08 ng/ml

Intra-assay (Within-Run)

n = 8; CV = 3.7%

Inter-assay (Run-to-Run)

n = 6; CV = 8.9%

Spiking Recovery

95,80%

Dilutation Linearity

102,10%

Crossreactivity

bovine Non-detectable

cat Non-detectable

dog Non-detectable

goat Non-detectable

hamster Non-detectable

horse Non-detectable

mouse Non-detectable

pig Non-detectable

rabbit Non-detectable

rat Non-detectable

sheep Non-detectable

chicken Not tested

human Yes

monkey Yes (recommended dilution 1:3)

Order Enquiry

Order Enquiry Form

References

– Buzga M, Evzen M, Pavel K, Tomas K, Vladislava Z, Pavel Z, Svagera Z. Effects of the Intragastric Balloon MedSil(R) on Weight Loss, Fat Tissue, Lipid Metabolism, and Hormones Involved in Energy Balance. Obes Surg. 2014 Feb 1;

– Lina Y, Lawrence GS, Wijaya A, As’ad S. Angiopoietin like protein 3 (Angptl3), fatty acid binding protein 4 (FABP4) and homeostasis model assessment of insulin resistance (HOMA-IR) among Indonesian obese non diabetic males. 2010;19 (3):185-190

– Robciuc MR, Tahvanainen E, Jauhiainen M, Ehnholm C. Quantitation of serum angiopoietin-like proteins 3 and 4 in a Finnish population sample. J Lipid Res. 2010 Apr;51 (4):824-31

– Stejskal D, Karpisek M, Humenanska V, Solichova P, Stejskal P. Angiopoietin-like protein 3: development, analytical characterization, and clinical testing of a new ELISA. Gen Physiol Biophys. 2007 Sep;26 (3):230-3

Enquiry